Literatur
Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabro MG, Grigoryev EV et al (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 376:2021–2031
Mehta RH, Leimberger JD, Van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D et al (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 376:2032–2042
Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P et al (2017) Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA 318:548–556
Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH (2013) Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 27:1224–1232
Putzu A, Clivio S, Belletti A, Cassina T (2018) Perioperative levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis. Int J Cardiol 251:22–31
Sanfilippo F, Knight JB, Scolletta S, Santonocito C, Pastore F, Lorini FL, Tritapepe L, Morelli A et al (2017) Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis. Crit Care 21:252
Treskatsch S, Balzer F, Geyer T, Spies CD, Kastrup M, Grubitzsch H, Wernecke KD, Erb JM et al (2015) Early levosimendan administration is associated with decreased mortality after cardiac surgery. J Crit Care 30(859):e851–e856
Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M (2009) Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 102:198–204
Theiss HD, Grabmaier U, Kreissl N, Hagl C, Steinbeck G, Sodian R, Franz WM, Kaczmarek I (2014) Preconditioning with levosimendan before implantation of left ventricular assist devices. Artif Organs 38:231–234
Kocabeyoglu SS, Kervan U, Sert DE, Karahan M, Aygun E, Beyazal OF, Unal EU, Akin Y et al (2020) Optimization with levosimendan improves outcomes after left ventricular assist device implantation. Eur J Cardiothorac Surg 57:176–182
Sugimura Y, Kalampokas N, Arikan M, Rellecke P, Dalyanoglu H, Tudorache I, Westenfeld R, Boeken U et al (2023) Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation. Interdiscip Cardiovasc Thorac Surg 1:ivac289
Guarracino F, Heringlake M, Cholley B, Bettex D, Bouchez S, Lomivorotov VV, Rajek A, Kivikko M et al (2018) Use of levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol 71:1–9
Greco T, Calabro MG, Covello RD, Greco M, Pasin L, Morelli A, Landoni G, Zangrillo A (2015) A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth 114:746–756
Habicher M, Zajonz T, Heringlake M, Boning A, Treskatsch S, Schirmer U, Markewitz A, Sander M (2018) S3 guidelines on intensive medical care of cardiac surgery patients : Hemodynamic monitoring and cardiovascular system—an update. Anaesthesist 67:375–379
Caruba T, Charles-Nelson A, Alexander JH, Mehta RH, Heringlake M, Toller W, Yavchitz A, Sabatier B et al (2022) Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: a pooled analysis of two multicentre randomised controlled trials. Anaesth Crit Care Pain Med 41:101107
Van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ et al (2020) Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. J Thorac Cardiovasc Surg 159:2302–2309 (e2306)
Wang W, Zhou X, Liao X, Liu B, Yu H (2019) The efficacy and safety of prophylactic use of levosimendan on patients undergoing coronary artery bypass graft: a systematic review and meta-analysis. J Anesth 33:543–550
Woehrle T, Mehringer L, Juchem G, Dashkevich A, Weis M, Schunemann M, Kilger E (2021) Individualized use of levosimendan in cardiac surgery. Anaesthesist 70:204–212
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Wöhrle und E. Kilger geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
Den dazugehörigen Artikel Contra: Levosimendan bei herzchirurgischen Eingriffen von Valerie Heinz und Gunther Wiesner finden Sie unter dem https://doi.org/10.1007/s00101-023-01361-6.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Wöhrle, T., Kilger, E. Pro: Levosimendan bei herzchirurgischen Eingriffen. Anaesthesiologie 73, 60–61 (2024). https://doi.org/10.1007/s00101-023-01360-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-023-01360-7